Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: TPL BK Pacers.. Here it is Laurie

This sums it all up, was on last page before the Appendix

-MIG will partner with TPL, PDS, its law firm partner and GreenArrays to bring its

vision to market.

-MIG expects to generate $200 million in licensing and litigation revenue over the

next five years, with nearly two thirds of the total revenue being returned to PDS for

distribution as royalties. This is achievable because MIG will create a small group of

licensing, business and engineering professionals to lead the effort for MMP.

-The TPL Group’s fortunes have been in decline for six years, and the probability of

the current team of resurrecting its brand is remote. Alliacense, TPL’s sister

company, remains a patent troll. Trolls have been under increasing, and

increasingly vocal, attack for years, and this reality is unlikely to change in the near

or distant future.

-MMP’s future is now, and that future should be led by Moore Innovations Group.

Share
New Message
Please login to post a reply